Imagion Biosystems Limited has announced “Form 605: Notice of ceasing to be a substantial holder.”
Read Form 605.
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal